UTHR Financial Facts

Selling, general and administrative: 94.11M
Operating income: 104.65M
See Full Income Statement

Total current liabilities: 687.67M
Other assets: 53.27M
See Full Balance Sheet

United Therapeutics Corp. (UTHR) Earnings

  |   Expand Research on UTHR
Next EPS Date N/A EPS Growth Rate +57.0%
Average EPS % Beat Rate +41.5% Revenue Growth Rate +19.6%
Average % Move 1-Wk after EPS +3.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
2/25/14 Q413 $2.88$1.51 +$1.37$289.02M$295.43M N/A -8.2% Details
10/29/13 Q313 $2.98$1.59 +$1.39$302.2M$279.02M +15% Details
7/25/13 Q213 $1.52$1.47 +$0.05$280.6M$250.17M +35.9% Details
4/25/13 Q113 $1.24$1.47 -$0.23$245.1M$241.14M +51.7% Details
2/26/13 Q412 $1.65$1.25 +$0.40$243.82M$233.41M +66.4% Details
2/14/13 Q412 N/A$1.24 N/A N/A$233.41M N/A N/A N/A
11/1/12 Q312 $1.52$1.26 +$0.26$242.5M$227.63M N/A +110.1% Details
7/26/12 Q212 $1.34$1.12 +$0.22$225.6M$213.33M N/A +90.3% Details